Cargando…

Competitive SARS-CoV-2 Serology Reveals Most Antibodies Targeting the Spike Receptor-Binding Domain Compete for ACE2 Binding

As severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to spread around the world, there is an urgent need for new assay formats to characterize the humoral response to infection. Here, we present an efficient, competitive serological assay that can simultaneously determine an ind...

Descripción completa

Detalles Bibliográficos
Autores principales:	Byrnes, James R., Zhou, Xin X., Lui, Irene, Elledge, Susanna K., Glasgow, Jeff E., Lim, Shion A., Loudermilk, Rita P., Chiu, Charles Y., Wang, Taia T., Wilson, Michael R., Leung, Kevin K., Wells, James A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7494835/ https://www.ncbi.nlm.nih.gov/pubmed/32938700 http://dx.doi.org/10.1128/mSphere.00802-20

Ejemplares similares

A SARS-CoV-2 serological assay to determine the presence of blocking antibodies that compete for human ACE2 binding
por: Byrnes, James R., et al.
Publicado: (2020)

Bi-paratopic and multivalent human VH domains neutralize SARS-CoV-2 by targeting distinct epitopes within the ACE2 binding interface of Spike
por: Bracken, Colton J., et al.
Publicado: (2020)

Bi-paratopic and multivalent VH domains block ACE2 binding and neutralize SARS-CoV-2
por: Bracken, Colton J., et al.
Publicado: (2020)

Engineering luminescent biosensors for point-of-care SARS-CoV-2 antibody detection
por: Elledge, Susanna K., et al.
Publicado: (2020)

Spike residue 403 affects binding of coronavirus spikes to human ACE2
por: Zech, Fabian, et al.
Publicado: (2021)

Engineering human ACE2 to optimize binding to the spike protein of SARS coronavirus 2
por: Chan, Kui K., et al.
Publicado: (2020)

SARS-CoV-2 spike and ACE2 entanglement-like binding
por: Pregnolato, Massimo, et al.
Publicado: (2023)

Cell-surface tethered promiscuous biotinylators enable comparative small-scale surface proteomic analysis of human extracellular vesicles and cells
por: Kirkemo, Lisa L, et al.
Publicado: (2022)

The sequence of human ACE2 is suboptimal for binding the S spike protein of SARS coronavirus 2
por: Procko, Erik
Publicado: (2020)

Revealing the Mechanism of SARS-CoV-2 Spike Protein Binding With ACE2
Publicado: (2020)

Mechanism and evolution of human ACE2 binding by SARS-CoV-2 spike
por: Wrobel, Antoni G.
Publicado: (2023)

Biophysical properties of the isolated spike protein binding helix of human ACE2
por: Das, Anirban, et al.
Publicado: (2021)

Synthetic carbohydrate-binding agents neutralize SARS-CoV-2 by inhibiting binding of the spike protein to ACE2
por: Francesconi, Oscar, et al.
Publicado: (2022)

Machine learning reveals the critical interactions for SARS-CoV-2 spike protein binding to ACE2
por: Pavlova, Anna, et al.
Publicado: (2022)

Reply to Liu et al.: Specific mutations matter in specificity and catalysis in ACE2
por: Glasgow, Jeff, et al.
Publicado: (2021)

Dual nature of human ACE2 glycosylation in binding to SARS-CoV-2 spike
por: Mehdipour, Ahmad Reza, et al.
Publicado: (2021)

Perturbation of ACE2 Structural Ensembles by SARS-CoV-2 Spike Protein Binding
por: Uyar, Arzu, et al.
Publicado: (2021)

SARS-CoV-2 spike binding to ACE2 is stronger and longer ranged with glycans
por: Huang, Yihan, et al.
Publicado: (2022)

Identifying Hotspots in Binding of SARS-CoV-2 Spike Glycoprotein and Human ACE2
por: Mendis, Jenny, et al.
Publicado: (2021)

SARS-COV-2 spike binding to ACE2 in living cells monitored by TR-FRET
por: Cecon, Erika, et al.
Publicado: (2022)

Modelling SARS-CoV-2 spike-protein mutation effects on ACE2 binding
por: Thakur, Shivani, et al.
Publicado: (2023)

Could Dermaseptin Analogue be a Competitive Inhibitor for ACE2 Towards Binding with Viral Spike Protein Causing COVID19?: Computational Investigation
por: Sekar, P. Chandra, et al.
Publicado: (2021)

Chloroquine and Hydroxychloroquine Interact Differently with ACE2 Domains Reported to Bind with the Coronavirus Spike Protein: Mediation by ACE2 Polymorphism
por: Badraoui, Riadh, et al.
Publicado: (2021)

Author Correction: Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2
por: Huo, Jiangdong, et al.
Publicado: (2020)

Author Correction: Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2
por: Huo, Jiandong, et al.
Publicado: (2021)

Engineered ACE2 receptor traps potently neutralize SARS-CoV-2
por: Glasgow, Anum, et al.
Publicado: (2020)

Engineered ACE2 receptor traps potently neutralize SARS-CoV-2
por: Glasgow, Anum, et al.
Publicado: (2020)

Bispecific VH/Fab antibodies targeting neutralizing and non-neutralizing Spike epitopes demonstrate enhanced potency against SARS-CoV-2
por: Lim, Shion A., et al.
Publicado: (2021)

Immunoglobulin yolk targeting spike 1, receptor binding domain of spike glycoprotein and nucleocapsid of SARS-CoV-2 blocking RBD-ACE2 binding interaction
por: Eka Saputri, Meliana, et al.
Publicado: (2022)

Sphingosine prevents binding of SARS–CoV-2 spike to its cellular receptor ACE2
por: Edwards, Michael J., et al.
Publicado: (2020)

The ACE2-binding interface of SARS-CoV-2 Spike inherently deflects immune recognition
por: Hattori, Takamitsu, et al.
Publicado: (2020)

The ACE2-binding Interface of SARS-CoV-2 Spike Inherently Deflects Immune Recognition
por: Hattori, Takamitsu, et al.
Publicado: (2021)

Dexamethasone inhibits SARS-CoV-2 spike pseudotyped virus viropexis by binding to ACE2
por: Zhang, Yongjing, et al.
Publicado: (2021)

ACE2-cytomimetic particles restrict SARS-Cov-2 spike protein binding to cellular targets
por: Strong, Thomas A., et al.
Publicado: (2021)

Plastic Antibodies Mimicking the ACE2 Receptor for Selective Binding of SARS‐CoV‐2 Spike
por: Batista, Alex D., et al.
Publicado: (2022)

Spike protein receptor-binding domains from SARS-CoV-2 variants of interest bind human ACE2 more tightly than the prototype spike protein
por: Charles, Jermilia, et al.
Publicado: (2023)

Factors that Affect the Binding of the N-Terminal Helix of Human ACE2 to Spike Protein of SARS-CoV2
por: Das, Anirban, et al.
Publicado: (2021)

Engaging the spikes: heparan sulfate facilitates SARS-CoV-2 spike protein binding to ACE2 and potentiates viral infection
por: Kalra, Rajkumar Singh, et al.
Publicado: (2021)

Identifying zoonotic origin of SARS-CoV-2 by modeling the binding affinity between Spike receptor-binding domain and host ACE2
por: Huang, Xiaoqiang, et al.
Publicado: (2020)

Development of a nano-luciferase based assay to measure the binding of SARS-CoV-2 spike receptor binding domain to ACE-2
por: Lima, Marcelo A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_q8iamrqimte4hsr3safmvg28tm